Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2021-07-12 00:00:00 ET · period of report 2021-07-08 · accession 0001171843-21-004833 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-12 | 2021-07-08 | ANIK | Loerop James | EVP Business Development | M - OptEx | $0.00 | +3,000 | 6,323 | +90% | $0 |
| D | 2021-07-12 | 2021-07-08 | ANIK | Loerop James | EVP Business Development | F - Tax | $43.24 | -731 | 5,592 | -12% | -$31.6K |
| D | 2021-07-12 | 2021-07-08 | ANIK | Loerop James | EVP Business Development | M - OptEx | $0.00 | +3,000 | 3,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-08 | M | A | 3,000 | $0.00 | 6,323 | D | — | — | (F1) Reflects the second vesting installment of RSUs granted on July 8, 2019. |
| 2 | Common | Common Stock | 2021-07-08 | F | D | 731 | $43.24 | 5,592 | D | — | — | (F2) Reflects an aggregate of 731 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on July 8, 2021. (F3) Reflects the closing price of ANIK common stock on July 8, 2021, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. |
| 3 | Derivative | Restricted Stock Unit | 2021-07-08 | M | A | 3,000 | $0.00 | 3,000 | D | $0.00 · — to — | 3,000 Common Stock | (F1) Reflects the second vesting installment of RSUs granted on July 8, 2019. |